PATENT CLAIM ANALYSIS

Application Number: 16197584
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-10
Patent Classification: ["514", "210020"]

Abstract:
Disclosed are compounds having potency in the modulation of NMDA receptor activity. Such compounds can be used in the treatment of conditions such as depression and related disorders. Orally delivered formulations and other pharmaceutically acceptable delivery forms of the compounds, including intravenous formulations, are also disclosed.

Claim (Index 4):
A method of treating dementia in a patient in need thereof, comprising administering to the patient a therapeutically effective amount of a compound having the formula: or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 98.0
- Lexical Diversity: 1.34211
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['16006125', '15337605', '14932579', '15049577', '15969200']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7866153114794362
- 35 USC 102 Novelty (BERT): 0.5074096078558751
- Combined Prediction Score: 0.7586947411170801
- Mean Citation Score: 256.371846
- Max Citation Score: 286.1169
- Similarity Product: 222.7497379315137

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test